摘要:
The present invention provides a mannose-based mRNA targeted delivery system and use thereof. The mRNA can encode one or more target polypeptides and contains at least one mannose modification. The technical solution of the present invention modifies the mRNA molecule with a mannose, so that the mRNA can be directly and efficiently coupled with the mannose, and the targeted delivery of the mRNA is realized without the need for a carrier.
摘要:
Provided herein are compounds for use as sialidase inhibitors, including alkynyl-3-fluorosialyl fluoride. The compounds, which include the compound DFSA, function by trapping a 3-fluorosialylenzyme intermediate (reporter-inhibitor-enzyme conjugate). These compounds can be conjugated with a detectable tagging moiety for isolation and identification of sialidases.
摘要:
The present invention relates to a novel family of alkylated halogenated di- and trisaccharides which exhibit pharmaceutical efficacy in the areas of permeation enhancers, anti-microbial effects, anti-fugal effects, facilitation of diagnostic procedures. The invention further includes methods of treatment and diagnostic kits.
摘要:
A smaller molecule obtainable by allowing a sulfated fucan-digesting enzyme which digests a novel sulfated polysaccharide derived from an alga belonging to Laminariales to act on a sulfated fucan, and a method for producing the same.
摘要:
A process for the preparation of lactosylurea and the N-methylol derivative thereof which are usable as feed supplements for ruminants.According to this process, lactose and urea are heated to 70.degree.-110.degree. C. with a minimum of water and, if possible, this water is eliminated during the reaction. The crude reaction product can be purified by grinding with ice-water or ethanol and subsequent draining so as to eliminate by dissolution in such solvants the unreacted urea.The corresponding N-methylol derivative is obtained by the reaction with formaldehyde.
摘要:
An inventive substrate is provided which includes a substrate compound of formula A-B1-B2-B3-B4: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 is a linker moiety with a free reactive amino group so as to be available for reaction with carboxylic acids or detectable tags; B3 contains a permanently charged element such as a quaternary ammonium group so as to increase sensitivity for mass spectrometry analysis; and B4 of various carbon length conferring specificity amongst individual substrates in detection methods. Also provided is a molecule of the formula B1-B2-B3-B4, with similar structural characteristics to an enzymatic product produced by the action of a target enzyme on an inventive substrate. Further provided are methods for using inventive substrates for detecting enzymatic activity.
摘要:
The present invention relates to a novel human gene that is differentially expressed in human carcinoma. More specifically, the present invention relates to a polynucleotide encoding a novel human polypeptide named C35 that is overexpressed in human breast and bladder carcinoma. This invention also relates to C35 polypeptides, as well as vectors, host cells, antibodies directed to C35 polypeptides, and the recombinant methods for producing the same. The present invention further relates to diagnostic methods for detecting carcinomas, including human breast carcinomas. The present invention further relates to the formulation and use of the C35 gene and polypeptides in immunogenic compositions or vaccines, to induce antibody or cell-mediated immunity against target cells, such as tumor cells, that express the C35 gene. The invention further relates to screening methods for identifying agonists and antagonists of C35 activity.
摘要:
There are disclosed aptamer ligands to MUC1, preferably comprising a sequence selected from: 1CGAATGGGCCCGTCCTCGCTGTAAG 2GCAACAGGGTATCCAAAGGATCAAA 3GTTCGACAGGAGGCTCACAACAGGC 4TGTTGGTCAGGCGGCGGCTCTACAT 5CTCTGTTCTTATTTGCGAGTTXXXX 6XCTCTGTTCTTATTTGCGAGTTXXX 7XXCTCTGTTCTTATTTGCGAGTTXX 8XXXCTCTGTTCTTATTTGCGAGTTX 9XXXXCTCTGTTCTTATTTGCGAGTT 10CTCTGTTCTTATTTGCGAGTT 11CCCTCTGTTCTTATTTGCGAGTTCA 12CTCTGTTCTTATTTGCGAGTTGGTG 13CCCTCTGTTCTTATTTGCGAGTTCA 14TAAGAACAGGGCGTCGTGTTACGAG 15GTGGCTTACTGCGAGGACGGGCCCA 16GCAGTTGATCCTTTGGATACCCTGG 17AACCCTATCCACTTTTCGGCTCGGG 18CGATTTAGTCTCTGTCTCTAGGGGT 19CGACAGGAGGCTCACAACAGGCAAC 20AGAACGAAGCGTTCGACAGGAGGCT 21AGAAACACTTGGTATATCGCAGATA 22GGGAGACAAGAATAAACACTCAACG and compounds comprising these aptamers and sequences. There are also disclosed compounds having the structure formula (I) and (II). There are also disclosed methods of treatment, diagnosis, detection and imaging using these compounds, their use in such methods, and their use in the preparation of medicaments and products for such methods.
摘要:
7-O-(4-Amino-2,4,6-trideoxy-2-fluoro-.alpha.-L-mannopyranosyl)-daunomycinone or -adriamycinone is now synthesized as a daunomycinone or adriamycinone derivative having the general formula ##STR1## wherein R is a hydrogen atom or hydroxyl group. These novel compounds according to this invention exhibit excellent antitumor activities and have a high solubility in water, and hence they are useful as an antitumor agent.
摘要:
Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.